Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Silva

Showing results (211-220 of 214) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 214 results.
Hepatology International|December 13, 2018
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri LankaMadunil Anuk Niriella, A Kasturiratne, A Pathmeswaran, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 22

Showing results (211-220 of 214) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 214 results.
Hepatology International|December 13, 2018
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri LankaMadunil Anuk Niriella, A Kasturiratne, A Pathmeswaran, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 22